$PFHO
PACIFIC HEALTH CARE ORGANIZATION INC

2022 Q4 Form 10-Q Financial Statement

#000118518522001309 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $1.463M $1.454M $1.311M
YoY Change 2.7% 10.94% -7.43%
Cost Of Revenue $377.1K $239.6K $208.4K
YoY Change 39.85% 14.96% -2.79%
Gross Profit $1.086M $1.214M $1.102M
YoY Change -5.97% 10.18% -8.25%
Gross Profit Margin 74.23% 83.52% 84.1%
Selling, General & Admin $1.111M $937.9K $982.8K
YoY Change -0.61% -4.57% -1.41%
% of Gross Profit 102.32% 77.22% 89.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.85K $9.661K $12.65K
YoY Change -16.09% -23.63% -10.47%
% of Gross Profit 1.0% 0.8% 1.15%
Operating Expenses $1.122M $1.187M $995.4K
YoY Change 12.47% 19.25% -1.53%
Operating Profit -$36.03K $266.9K $106.8K
YoY Change -122.89% 149.87% -43.91%
Interest Expense $27.20K $0.00 $0.00
YoY Change -1913.33%
% of Operating Profit 0.0% 0.0%
Other Income/Expense, Net $2.898K $11.92K
YoY Change -75.68%
Pretax Income -$8.840K $266.9K $106.8K
YoY Change -102.35% 149.87% -43.91%
Income Tax $3.340K $74.93K $29.99K
% Of Pretax Income 28.07% 28.07%
Net Earnings -$12.18K $192.0K $76.85K
YoY Change -103.85% 149.84% -43.91%
Net Earnings / Revenue -0.83% 13.21% 5.86%
Basic Earnings Per Share $0.02 $0.01
Diluted Earnings Per Share $0.00 $0.01 $5.996K
COMMON SHARES
Basic Shares Outstanding 12.80M shares 12.80M shares 12.80M shares
Diluted Shares Outstanding 12.82M shares 12.82M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.78M $10.64M $10.16M
YoY Change 6.94% 4.78% 10.23%
Cash & Equivalents $2.036M $10.64M $10.16M
Short-Term Investments $8.748M
Other Short-Term Assets $175.4K $157.3K $74.82K
YoY Change 63.83% 110.29% -39.09%
Inventory
Prepaid Expenses $175.4K $157.3K
Receivables $935.0K $864.1K $786.1K
Other Receivables $3.000K $3.000K $3.000K
Total Short-Term Assets $11.90M $11.66M $11.02M
YoY Change 6.78% 5.86% 6.26%
LONG-TERM ASSETS
Property, Plant & Equipment $97.41K $87.00K $237.9K
YoY Change 5.26% -63.43% -52.74%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.602K $6.602K $26.79K
YoY Change -75.35% -75.36% 0.0%
Total Long-Term Assets $154.1K $93.60K $264.7K
YoY Change -18.74% -64.63% -50.07%
TOTAL ASSETS
Total Short-Term Assets $11.90M $11.66M $11.02M
Total Long-Term Assets $154.1K $93.60K $264.7K
Total Assets $12.05M $11.76M $11.28M
YoY Change 6.35% 4.2% 3.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $263.0K $89.34K $59.01K
YoY Change 485.81% 51.39% 23.56%
Accrued Expenses $332.6K $247.3K $394.1K
YoY Change 5.41% -37.26% -27.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $35.02K
YoY Change -88.74%
Total Short-Term Liabilities $708.9K $421.5K $591.7K
YoY Change 41.4% -28.77% -39.54%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $183.9K
YoY Change -100.0% 22.93%
Other Long-Term Liabilities $10.52K $0.00 $0.00
YoY Change -100.0%
Total Long-Term Liabilities $10.52K $0.00 $183.9K
YoY Change -100.0% -33.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $708.9K $421.5K $591.7K
Total Long-Term Liabilities $10.52K $0.00 $183.9K
Total Liabilities $735.1K $428.6K $775.5K
YoY Change 44.57% -44.73% -38.14%
SHAREHOLDERS EQUITY
Retained Earnings $10.89M $10.90M
YoY Change 4.74%
Common Stock $12.80K $12.80K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.32M $11.33M $10.51M
YoY Change
Total Liabilities & Shareholders Equity $12.05M $11.76M $11.28M
YoY Change 6.35% 4.2% 3.52%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$12.18K $192.0K $76.85K
YoY Change -103.85% 149.84% -43.91%
Depreciation, Depletion And Amortization $10.85K $9.661K $12.65K
YoY Change -16.09% -23.63% -10.47%
Cash From Operating Activities $138.9K $231.9K $61.28K
YoY Change -318.44% 278.36% -76.06%
INVESTING ACTIVITIES
Capital Expenditures $21.25K -$450.00 -$6.770K
YoY Change -443.85% -93.35% -33.76%
Acquisitions
YoY Change
Other Investing Activities -$8.721M
YoY Change
Cash From Investing Activities -$8.743M -$450.00 -$6.770K
YoY Change 141365.37% -93.35% -33.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 138.9K 231.9K 61.28K
Cash From Investing Activities -8.743M -450.0 -6.770K
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -8.604M 231.4K 54.51K
YoY Change 12229.65% 324.53% -77.82%
FREE CASH FLOW
Cash From Operating Activities $138.9K $231.9K $61.28K
Capital Expenditures $21.25K -$450.00 -$6.770K
Free Cash Flow $117.7K $232.3K $68.05K
YoY Change -304.95% 241.38% -74.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-50009
dei Entity Registrant Name
EntityRegistrantName
PACIFIC HEALTH CARE ORGANIZATION, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0285238
dei Entity Address Address Line1
EntityAddressAddressLine1
19800 MacArthur Boulevard, Suites 306 & 307
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
721-8272
dei Security12b Title
Security12bTitle
None
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei No Trading Symbol Flag
NoTradingSymbolFlag
true
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12800000 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10640063 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10085372 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7696 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23083 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
864070 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
927990 usd
CY2022Q3 us-gaap Deferred Rent Asset Net Current
DeferredRentAssetNetCurrent
0 usd
CY2021Q4 us-gaap Deferred Rent Asset Net Current
DeferredRentAssetNetCurrent
10055 usd
CY2022Q3 us-gaap Other Receivables
OtherReceivables
3000 usd
CY2021Q4 us-gaap Other Receivables
OtherReceivables
3000 usd
CY2022Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 usd
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
19779 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
157336 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
96977 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
11664469 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
11143173 usd
CY2022Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
277716 usd
CY2021Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
526249 usd
CY2022Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
20928 usd
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
226323 usd
CY2022Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
0 usd
CY2021Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
9556 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
298644 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
762128 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
211642 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
669592 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
87002 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
92536 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
70368 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6602 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26788 usd
CY2022Q3 us-gaap Assets
Assets
11758073 usd
CY2021Q4 us-gaap Assets
Assets
11332865 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
89337 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
44899 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
247274 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
315495 usd
CY2022Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
37000 usd
CY2021Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
37000 usd
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
7316 usd
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70368 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
40523 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
33544 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
421450 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
501306 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7154 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7154 usd
CY2022Q3 us-gaap Liabilities
Liabilities
428604 usd
CY2021Q4 us-gaap Liabilities
Liabilities
508460 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10900596 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10395532 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
11329469 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10824405 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11758073 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11332865 usd
CY2022Q3 us-gaap Revenues
Revenues
1453997 usd
CY2021Q3 us-gaap Revenues
Revenues
1310618 usd
us-gaap Revenues
Revenues
4281831 usd
us-gaap Revenues
Revenues
3978431 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9661 usd
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12657 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23153 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
35964 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-5520 usd
CY2021Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-737 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
494 usd
CY2022Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
56148 usd
CY2021Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
58275 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
166309 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
173796 usd
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
699026 usd
CY2021Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
679530 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
2018638 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
2073133 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
76065 usd
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
76014 usd
us-gaap Professional Fees
ProfessionalFees
222703 usd
us-gaap Professional Fees
ProfessionalFees
221970 usd
CY2022Q3 us-gaap General Insurance Expense
GeneralInsuranceExpense
79974 usd
CY2021Q3 us-gaap General Insurance Expense
GeneralInsuranceExpense
86527 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
238851 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
242334 usd
CY2022Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
156677 usd
CY2021Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
109926 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
433275 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
304085 usd
CY2022Q3 us-gaap Other Expenses
OtherExpenses
2898 usd
CY2021Q3 us-gaap Other Expenses
OtherExpenses
11917 usd
us-gaap Other Expenses
OtherExpenses
59400 usd
us-gaap Other Expenses
OtherExpenses
75293 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
112135 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
168939 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
418079 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
492264 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1187064 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
1203785 usd
us-gaap Operating Expenses
OperatingExpenses
3579671 usd
us-gaap Operating Expenses
OperatingExpenses
3619333 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
266933 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
106833 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
702160 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
359098 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3686 usd
CY2022Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
CY2021Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
464386 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
11329469 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
460700 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
266933 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
106833 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
702160 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
819798 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
74928 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29987 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
197096 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
140956 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
192005 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
76846 usd
us-gaap Net Income Loss
NetIncomeLoss
505064 usd
us-gaap Net Income Loss
NetIncomeLoss
678842 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
9829385 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
507285 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
10336670 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
94711 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
10431381 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
76846 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
10508227 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10824405 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
188535 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
11012940 usd
us-gaap Net Income Loss
NetIncomeLoss
505064 usd
us-gaap Net Income Loss
NetIncomeLoss
678842 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23153 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
124524 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
11137464 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
192005 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
35964 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-737 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
494 usd
us-gaap Debt Instrument Increase Decrease For Period Net
DebtInstrumentIncreaseDecreaseForPeriodNet
0 usd
us-gaap Debt Instrument Increase Decrease For Period Net
DebtInstrumentIncreaseDecreaseForPeriodNet
460700 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-64657 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-276484 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
60359 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-8287 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
44438 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-21129 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
0 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-2725 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-19779 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-68221 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-19643 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7316 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-52045 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-10055 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
607 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-20186 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6979 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5771 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
572310 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
449993 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17619 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12199 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17619 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12199 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
0 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
218900 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
218900 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
554691 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
656694 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10085372 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9498457 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10640063 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10155151 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
3686 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
170000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
69000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7696 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
23083 usd
CY2015Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P79M
CY2015Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
9439 sqft
CY2022Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2022Q2 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
320 sqft
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
9903 usd
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
80246 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
19806 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
204651 usd
CY2021Q1 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
460700 usd
CY2021Q4 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
218900 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Entity Central Index Key
EntityCentralIndexKey
0001138476

Files In Submission

Name View Source Status
0001185185-22-001309-index-headers.html Edgar Link pending
0001185185-22-001309-index.html Edgar Link pending
0001185185-22-001309.txt Edgar Link pending
0001185185-22-001309-xbrl.zip Edgar Link pending
ex_446718.htm Edgar Link pending
ex_446719.htm Edgar Link pending
ex_446720.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pacifichco20220930_10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pacifichco20220930_10q_htm.xml Edgar Link completed
pfho-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pfho-20220930_cal.xml Edgar Link unprocessable
pfho-20220930_def.xml Edgar Link unprocessable
pfho-20220930_lab.xml Edgar Link unprocessable
pfho-20220930_pre.xml Edgar Link unprocessable